Analysts Set Definitive Healthcare Corp. (NASDAQ:DH) PT at $1.47

Definitive Healthcare Corp. (NASDAQ:DH) has been given an average recommendation of “Reduce” by the nine ratings firms that are presently covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $1.4714.

A number of research analysts have issued reports on DH shares. Morgan Stanley reduced their price objective on Definitive Healthcare from $2.50 to $1.50 and set an “equal weight” rating for the company in a research note on Tuesday, August 11th. Wall Street Zen upgraded shares of Definitive Healthcare from a “hold” rating to a “buy” rating in a research note on Sunday, July 26th. Bank of America reaffirmed an “underperform” rating and set a $0.70 target price on shares of Definitive Healthcare in a report on Monday, June 29th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Definitive Healthcare in a report on Wednesday, June 3rd. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $1.00 price objective on shares of Definitive Healthcare in a research report on Wednesday, August 12th.

Hedge Funds Weigh In On Definitive Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the company. Goldman Sachs Group Inc. boosted its position in shares of Definitive Healthcare by 564.2% during the first quarter. Goldman Sachs Group Inc. now owns 8,716,725 shares of the company’s stock valued at $25,191,000 after purchasing an additional 7,404,363 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Definitive Healthcare by 1.6% in the 3rd quarter. Dimensional Fund Advisors LP now owns 2,073,197 shares of the company’s stock worth $8,417,000 after acquiring an additional 33,612 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its stake in shares of Definitive Healthcare by 11.7% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 1,216,007 shares of the company’s stock worth $4,937,000 after acquiring an additional 127,055 shares in the last quarter. Bank of America Corp DE lifted its position in Definitive Healthcare by 23.7% during the 2nd quarter. Bank of America Corp DE now owns 769,397 shares of the company’s stock valued at $3,001,000 after acquiring an additional 147,599 shares during the period. Finally, Inspire Investing LLC lifted its position in Definitive Healthcare by 505.7% during the 4th quarter. Inspire Investing LLC now owns 698,967 shares of the company’s stock valued at $2,006,000 after acquiring an additional 583,562 shares during the period. 98.67% of the stock is owned by institutional investors.

Definitive Healthcare Stock Performance

Shares of DH stock opened at $0.71 on Friday. Definitive Healthcare has a 52-week low of $0.61 and a 52-week high of $4.35. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.86 and a current ratio of 1.86. The company has a 50-day simple moving average of $0.74 and a two-hundred day simple moving average of $1.00. The company has a market capitalization of $76.23 million, a price-to-earnings ratio of -0.45, a PEG ratio of 8.81 and a beta of 1.35.

Definitive Healthcare (NASDAQ:DH) last posted its earnings results on Monday, August 10th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.04 by $0.01. Definitive Healthcare had a negative net margin of 72.28% and a positive return on equity of 3.55%. The firm had revenue of $55.20 million for the quarter, compared to analysts’ expectations of $55.47 million. Definitive Healthcare has set its FY 2026 guidance at 0.180-0.200 EPS and its Q3 2026 guidance at 0.040-0.050 EPS. Research analysts anticipate that Definitive Healthcare will post 0.06 EPS for the current fiscal year.

About Definitive Healthcare

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.